Yunnan Baiyao, the general manager of traditional Chinese medicine, is the first national brand of traditional Chinese medicine in China and the first brand of domestic toothpaste, with Yunnan Baiyao series, Sanqi series and Yunnan national characteristic medicine series as its main products. The market share of Nanbaiyao toothpaste is about 18. 1%, ranking second in China.
Wuxi pharmatech, the leader of new drug experiment, is the world's leading "integrated, end-to-end" service platform for new drug research and development. CDMO business has increased the flexibility of the company's performance. 202 1 Q 1 operating income and adjusted non-IFRS net profit increased by 55.3 1% and 63.6% respectively, which continued to show ultra-high growth and exceeded market expectations.
Tonghua dongbao, a leading diabetic, has a recombinant human insulin product, which fills the domestic gap and becomes one of the global large-scale human insulin production bases.
Xinhecheng, a leading vitamin drug, is the largest manufacturer of vitamin A and vitamin E in China. This company is one of the leading fine chemical companies, and has a strong market position and pricing power in many products.
Hualan Bio, the leader of blood products, the leading enterprise of domestic blood products and vaccine products, and the leading influenza vaccine, exclusively supplies domestic tetravalent influenza vaccine, and has the largest influenza vaccine production base in China.
Changchun Hi-Tech, growth hormone faucet, chicken pox vaccine faucet; Changchun Encyclopedia, a subsidiary of Changchun Encyclopedia, has a chicken pox vaccine-preventing chicken pox, with the first market share.
Aier Ophthalmology, a leading ophthalmology service provider, is one of the largest ophthalmology medical institutions in China, a leading chain enterprise of private ophthalmology hospitals, ranking first in the world in terms of revenue, number of hospitals, number of outpatients and operations.
Tongce Medical, a leading dental service provider and a leading dental medical platform provider and service provider, got rid of the negative impact of the epidemic and achieved rapid growth in the second half of 2020 and 20021q1.
Zheng Qi, a leading Tibetan medicine enterprise in China, developed the second and third echelon with the strategy of "strengthening analgesia", and achieved remarkable results.
Dongcheng Pharmaceutical Co., Ltd., a leading nuclear medicine company, has always ranked fourth in the industry in the export volume of heparin sodium raw materials; The company's export market share rose to 12.28%, ranking third in the industry; Chondroitin sulfate products ranked first in export.
Yu Yue Medical, the leader of household medical devices, is the leader of medical devices in China, ranking first in the market share of products such as oxygen generator, sphygmomanometer, surgical instruments, atomizer, stethoscope, wheelchair and acupuncture needle.
Dabo Medical, the leader of orthopedic materials, is one of the leading enterprises in the field of orthopedic implant medical consumables in China. Its products include orthopedic trauma implants, spinal implants and neurosurgery implants.
Lepu Medical, the leader of cardiac stent, the leader of domestic cardiovascular equipment and the pharmaceutical sector, provides the company with long-term and stable cash flow, with declining income but steady growth in profits.
Yao Bo is a leading manufacturer of medical glass and the largest pharmaceutical glass packaging enterprise in China. In the first quarter, it was 202 1.7%, 14.9% and 13.5% respectively. The overall performance is in line with expectations.
Kangtai Bio, a leading vaccine producer, is one of the richest companies in China vaccine research and development platform. The dosage form of quadruple vaccine was upgraded, and the production capacity of hepatitis B vaccine was improved.
Tiger Medicine, the leader of clinical CRO, and its subsidiary Jietong Terry are leading CRO enterprises focusing on medical devices in China, and their domestic business recovery is ideal, driving their performance to improve quarter by quarter.
Jinyu Medicine, a leading independent laboratory, is a high-tech service enterprise with the core of third-party medical examination and pathological diagnosis. In the first quarter, the company's nucleic acid detection and routine inspection business both increased, and its performance exceeded market expectations.
Antu Bio, the leader of chemiluminescence diagnostic reagents, has a rich product line, leading the industry in the variety and quantity of luminescent diagnostic reagents, and the overall performance is in line with expectations.
Fan Jian Bio, the leader of hemoperfusion equipment, the absolute leader in hemoperfusion segmentation, and the only listed company; The main product is hemoperfusion device.
Yifeng Pharmacy, pharmacy leader, large-scale pharmaceutical chain private enterprise, the growth rate of pharmacy industry slowed down in the first quarter, and the company's performance indicators led the industry.
Wuwu Biological, the leading enterprise of antiallergic biological drugs, is the only sublingual desensitization drug manufacturer in China. Its main products are allergen products used to diagnose and treat allergic diseases. The vaccine business grew rapidly and its performance exceeded market expectations.